Neo-adjuvant chemotherapy in early stage non-small cell lung cancer

Journal of Thoracic Disease

Volumn 5, Issue SUPPL.4, 2013, Pages

  Boukovinas, Ioannis ^a   Tsakiridis, Kosmas ^b   Zarogoulidis, Paul ^c   Machairiotis, Nikolaos ^d   Katsikogiannis, Nikolaos ^d   Kougioumtzi, Ioanna ^d   Zarogoulidis, Kostantinos ^a  

^a THEAGENIO CANCER HOSPITAL   (Greece)

^b Saint Luke Private Hospital   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d UNIVERSITY GENERAL HOSPITAL OF ALEXANDROUPOLIS   (Greece)

Author keywords

Early stage; Lung cancer; Neo adjuvant

Indexed keywords

CARBOPLATIN; CISPLATIN; GEMCITABINE; NAVELBINE; PACLITAXEL;

CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL (TOPIC); DISEASE FREE SURVIVAL; HUMAN; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; MEDICATION COMPLIANCE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PREOPERATIVE TREATMENT; PROGRESSION FREE SURVIVAL; RECURRENCE FREE SURVIVAL; SHORT SURVEY; SURVIVAL TIME;

EID: 84901496684     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.3978/j.issn.2072-1439.2013.07.36     Document Type: Short Survey

References (9)

1. Burdett S, Stewart LA, Rydzewska L. A systematic review and meta-analysis of the literature: chemotherapy and surgery versus surgery alone in nonsmall cell lung cancer. J Thorac Oncol 2006;1:611-21.
2. Depierre A, Milleron B, Moro-Sibilot D, et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer. J Clin Oncol 2002;20:247-53.
3. Westeel V, Milleron BJ, Quoix EA, et al. Long-term results of the French randomized trial comparing neoadjuvant chemotherapy followed by surgery versus surgery alone in resectable non-small cell lung cancer. J Clin Oncol 2010;28:abstr 7003.
4. Gilligan D, Nicolson M, Smith I, et al. Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review. Lancet 2007;369:1929-37.
5. Pisters KM, Vallières E, Crowley JJ, et al. Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial. J Clin Oncol 2010;28:1843-9.
6. Felip E, Rosell R, Maestre JA, et al. Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage non-small-cell lung cancer. J Clin Oncol 2010;28:3138-45.
7. Scagliotti GV, Pastorino U, Vansteenkiste JF, et al. A phase III randomized study of surgery alone or surgery plus preoperative gemcitabine-cisplatin in early-stage non small cell lung cancer: follow-up data of CH.E.S.T. J Clin Oncol 2008;26:abstr 7508.
8. Crinò L, Weder W, van Meerbeeck J, et al. Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21 Suppl 5:v103-15.
9. Bradbury PA, Shepherd FA. Chemotherapy and surgery for operable NSCLC. Lancet 2007;369:1903-4.